Beta Bionics updates Mint patch pump commercialization timeline to Q2 2027
Beta Bionics announced it expects to fully commercialize its Mint patch pump by the end of Q2 2027, subject to FDA regulatory clearance, based on positive FDA responses and manufacturing scaling progress. The product aims to expand insulin pump options for diabetes patients by of
View filing at SEC.gov →